Skip to Main content Skip to Navigation
Journal articles

Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis

Valentine Heidelberger Saskia Ingen-Housz-Oro 1 Alicia Marquet Matthieu Mahevas 2 Didier Bessis 3 Laurence Bouillet 4 Frédéric Caux 5 Catherine Chapelon-Abric 6 Sebastien Debarbieux 7 Emmanuel Delaporte 8 Anne-Bénédicte Duval-Modeste 9 Olivier Fain 10 Pascal Joly 9, 11 Sylvain Marchand-Adam 12 Jean-Benoît Monfort 13 Nicolas Noel 14 Thierry Passeron 15 Marc Ruivard 16 Françoise Sarrot-Reynauld 4 Denis Verrot Diane Bouvry 17 Laurence Fardet 18 Olivier Chosidow 19 Pascal Sève 20 Dominique Valeyre 17
Abstract : Evidence for the long-term efficacy and safety of anti-tumor necrosis factor α agents (anti-TNF) in treating cutaneous sarcoidosis is lacking.
Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-02377658
Contributor : Yossan-Var Tan Connect in order to contact the contributor
Submitted on : Sunday, November 24, 2019 - 9:51:11 AM
Last modification on : Tuesday, January 11, 2022 - 5:56:30 PM

Links full text

Identifiers

Citation

Valentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, Matthieu Mahevas, Didier Bessis, et al.. Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis. JAMA Dermatology, American Medical Association, 2017, 153 (7), pp.681. ⟨10.1001/jamadermatol.2017.1162⟩. ⟨hal-02377658⟩

Share

Metrics

Les métriques sont temporairement indisponibles